PATENT CLAIM ANALYSIS

Application Number: 15755356
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "604000"]

Abstract:
Compounds of formula (I) having 1-sulfonamido-4-aryloxy as a basic backbone. A preliminary activity test showed that the compounds provide excellent interference of a binding of Nrf2 by Keap1, thereby activating Nrf2. The compounds have a potential anti-inflammatory activity and can be used to treat a plurality of inflammation-associated diseases, including chronic obstructive pulmonary disease (COPD), Alzheimer's disease, Parkinson's disease, atherosclerosis, chronic kidney disease (CKD), diabetes, gastroenteritis, rheumatoid arthritis, and the like.

Claim (Index 6):
The compound according to  claim 1  or a pharmaceutically acceptable salt thereof, wherein the pharmaceutically acceptable salt is a sodium, potassium or calcium carboxylates of the compound of Formula (I).

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.5082
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10270259', '09972743', '11909136', '12601284', '15750427']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7234845558989849
- 35 USC 102 Novelty (BERT): 0.4860760201049341
- Combined Prediction Score: 0.6997437023195798
- Mean Citation Score: 164.202382
- Max Citation Score: 167.51404
- Similarity Product: 121.16592714741944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test